Arm vs. Intel: Which Technology Stock Is a Better Buy in 2026?

Arm is favored over Intel on the strength of its asset-light licensing model: fiscal 2026 revenue rose 22.8% to $4.9B, net income reached $904M, and free cash flow was $979M. Intel's fiscal 2025 revenue slipped 0.5% to $52.9B, it posted a $267M net loss, and free cash flow was negative $4.9B amid its capital-intensive foundry turnaround. Arm's 115.2x forward P/E and 55.7x P/S leave limited room for execution disappointment, while Intel faces manufacturing, competitive, political, and shareholder-litigation risks tied to the U.S. government's roughly 10% stake.

Analysis

ARM’s key upside is not unit growth in mature handsets but royalty-rate expansion from Armv9 adoption and server-class designs. The market is underwriting a sustained mix shift sufficiently large to justify an extreme revenue multiple; that makes quarterly royalty-per-chip, hyperscaler CPU design wins, and China licensing trends more important than headline revenue growth. SBC-adjusted cash conversion is materially weaker than the asset-light narrative implies, creating dilution risk if the valuation remains elevated while growth normalizes.

INTC’s foundry strategy has a structural customer-conflict problem: prospective customers must trust Intel with sensitive designs while Intel remains a competing merchant CPU vendor. This favors TSM as the default external-manufacturing beneficiary if Intel’s yield, delivery, or customer-acquisition milestones slip, while government support may reduce insolvency risk without improving return on invested capital. Over the next 1-3 months, the relevant catalysts are foundry customer disclosures, 18A yield/ramp commentary, and capex reductions; over 6-18 months, utilization—not announced capacity—determines whether the fixed-cost base can recover margins.

Consensus is too binary in treating ARM as the quality compounder and INTC as the broken turnaround. ARM can remain strategically advantaged yet deliver weak equity returns if licensing growth decelerates even modestly against its embedded expectations; conversely, INTC has asymmetric upside only if it secures credible external volume commitments, not merely government backing. A broad AI-capex slowdown would pressure both, but ARM’s multiple duration creates greater near-term downside sensitivity while TSM has the clearer production-volume capture.

Key Decisions for Investors

• Prefer a 6-12 month long TSM / short INTC pair rather than directional INTC exposure. TSM captures outsourced leading-edge demand with less execution ambiguity; cover the short if Intel reports named, volume-bearing external foundry customers or demonstrates sustained 18A yield and utilization improvement.
• Do not chase ARM following strength; establish only on a 15-20% pullback or after a quarterly print confirms accelerating royalty revenue and higher royalty-per-unit. Size small: a valuation de-rating from growth disappointment can overwhelm operational upside over the next 1-3 months.
• For an existing ARM long, use a 3-6 month collar or reduce exposure ahead of earnings if management does not quantify data-center royalty contribution. Thesis is falsified by decelerating royalty growth, renewed handset weakness, or incremental dilution that prevents per-share FCF scaling.
• Treat INTC as an event-driven watch item, not a core value long. Revisit only after capex discipline and foundry backlog/customer economics are disclosed; absent those data, negative FCF and low utilization leave downside risk disproportionate to the apparent valuation discount.